From: Intravitreal sirolimus with adjunct aflibercept versus aflibercept monotherapy for persistent, exudative age-related macular degeneration: a pilot study
Treatment group (sirolimus + aflibercept)
Control group (aflibercept monotherapy)
Systemic events
Serious adverse events
3a
0
Minor adverse events
4
2
Ocular events